Prognostic Factors and Therapeutic Management of ESBL Enterobacteriaceae in the ICU (BLSE-REA)

Tourcoing Hospital

Status: Enrolling

Conditions: Drug Resistance, Multiple, Bacterial

Study type: Observational

Funder types: Other

Identifiers

NCT05833282

NRIPH_2023_01

Details and patient eligibility

About

Multicenter retrospective study conducted in the intensive care units of Tourcoing, Roubaix, and Lille hospitals. Patients hospitalized in the ICU with EBLSE bacteremia within 24 hours before or during their stay in the ICU will be selected from microbiology laboratory data. Patient demographics and clinical data will be collected from the medical record. Microbiological results will be collected from the laboratory data.

Full description

INCLUSION CRITERIA - Patients admitted to the ICU with EBLSE bacteremia within 24 hours before or during their stay in the ICU.

PRIMARY ENDPOINT

• The primary endpoint is 30-day mortality.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients admitted to the ICU with EBLSE bacteremia within 24 hours before or during their stay in the ICU.

Exclusion criteria

• Patient who is a minor, protected adult, or who refuses to participate.